COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma

Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsova, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Schadendorf, Dirk; Yamazaki, Naoya; di Pietro, Alessandra; Cantey-Kiser, Jean; Edwards, Michelle; Ascierto, Paolo A.

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2023-11-24T09:48:21Z
dc.date.available	2023-11-24T09:48:21Z
dc.date.issued	2022
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/10900/148061
dc.language.iso	en	en
dc.publisher	Philadelphia : Lippincott Williams & Wilkins	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.21.02659
dc.subject.ddc	610	de_DE
dc.title	COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230925000000_00108
utue.publikation.seiten	4178	de_DE
utue.personen.roh	Dummer, Reinhard
utue.personen.roh	Flaherty, Keith T.
utue.personen.roh	Robert, Caroline
utue.personen.roh	Arance, Ana
utue.personen.roh	de Groot, Jan Willem B.
utue.personen.roh	Garbe, Claus
utue.personen.roh	Gogas, Helen J.
utue.personen.roh	Gutzmer, Ralf
utue.personen.roh	Krajsova, Ivana
utue.personen.roh	Liszkay, Gabriella
utue.personen.roh	Loquai, Carmen
utue.personen.roh	Mandala, Mario
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Yamazaki, Naoya
utue.personen.roh	di Pietro, Alessandra
utue.personen.roh	Cantey-Kiser, Jean
utue.personen.roh	Edwards, Michelle
utue.personen.roh	Ascierto, Paolo A.
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	36	de_DE
dcterms.isPartOf.ZS-Volume	40	de_DE
utue.fakultaet	04 Medizinische Fakultät